Organon & Co.
DE ˙ XTRA
11,54 € ↑0,06 (0,52%)
2026-06-03
AKTIENPREIS
SecurityDE:7XP / Organon & Co.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 7XP / Organon & Co.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Organon & Co. (DE:7XP). This represents 0.0 percent ownership of the company. In their previous filing dated 2025-10-30 , Vanguard Group Inc had reported owning 35,927,524 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 35,927,524 0 -100.00 0.00 -100.00
2025-10-30 2025-10-30 13G/A 30,596,708 35,927,524 17.42 13.82 15.46
2024-02-13 2024-02-13 13G/A 31,471,695 30,596,708 -2.78 11.97 -3.23
2023-02-09 2023-02-09 13G/A 28,774,673 31,471,695 9.37 12.37 8.99
2022-02-10 2022-02-10 13G/A 28,912,240 28,774,673 -0.48 11.35 -0.44
2021-07-12 2021-07-12 13G 28,912,240 11.40

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ORGANON COMMON STOCK 68622V106 36,916,382 987,979 2.75 264,690 -31.02 0.0038
2025-11-07 2025-09-30 13F ORGANON COMMON STOCK 68622V106 35,928,403 3,650,860 11.31 383,715 22.81 0.0057
2025-08-11 2025-06-30 13F ORGANON COMMON STOCK 68622V106 32,277,543 2,575,810 8.67 312,447 -29.35 0.0051
2025-05-09 2025-03-31 13F ORGANON COMMON STOCK 68622V106 29,701,733 -699,976 -2.30 442,259 -2.50 0.0080
2025-02-11 2024-12-31 13F ORGANON COMMON STOCK 68622V106 30,401,709 218,165 0.72 453,593 -21.44 0.0079
2024-11-13 2024-09-30 13F ORGANON COMMON STOCK 68622V106 30,183,544 -29,632 -0.10 577,411 -7.68 0.0103
2024-08-13 2024-06-30 13F ORGANON COMMON STOCK 68622V106 30,213,176 -576,674 -1.87 625,413 8.04 0.0120
2024-05-10 2024-03-31 13F ORGANON COMMON STOCK 68622V106 30,789,850 192,613 0.63 578,849 31.20 0.0115
2024-03-11 2023-12-31 13F/A-1 ORGANON COMMON STOCK 68622V106 30,597,237 -832,896 -2.65 441,212 -19.14 0.0096
2024-02-14 2023-12-31 13F ORGANON COMMON STOCK 68622V106 30,597,237 -832,896 441,212 0.0084
2023-12-18 2023-09-30 13F/A-1 ORGANON COMMON STOCK 68622V106 31,430,133 -237,674 -0.75 545,627 -17.20 0.0134
2023-11-14 2023-09-30 13F ORGANON COMMON STOCK 68622V106 31,430,133 -237,674 545,627 0.0134
2023-08-14 2023-06-30 13F ORGANON COMMON STOCK 68622V106 31,667,807 -8,446 -0.03 659,007 -11.55 0.0156
2023-07-14 2023-03-31 13F/A-1 ORGANON COMMON STOCK 68622V106 31,676,253 204,558 0.65 745,025 -15.24 0.0190
2023-05-15 2023-03-31 13F ORGANON COMMON STOCK 68622V106 31,675,723 204,028 745,013 0.0190
2023-02-10 2022-12-31 13F ORGANON COMMON STOCK 68622V106 31,471,695 1,241,224 4.11 879,004 24.26 0.0239
2022-11-14 2022-09-30 13F ORGANON COMMON STOCK 68622V106 30,230,471 536,373 1.81 707,394 -29.41 0.0208
2022-08-12 2022-06-30 13F ORGANON COMMON STOCK 68622V106 29,694,098 537,681 1.84 1,002,177 -1.60 0.0282
2022-05-13 2022-03-31 13F ORGANON COMMON STOCK 68622V106 29,156,417 381,744 1.33 1,018,434 16.23 0.0241
2022-02-14 2021-12-31 13F ORGANON COMMON STOCK 68622V106 28,774,673 -34,013 -0.12 876,188 -7.25 0.0199
2021-11-12 2021-09-30 13F ORGANON COMMON STOCK 68622V106 28,808,686 -103,554 -0.36 944,636 7.97 0.0235
2021-08-13 2021-06-30 13F ORGANON COMMON STOCK 68622V106 28,912,240 28,912,240 874,885 0.0218
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.